NUZ neurizon therapeutics limited

Ann: Positive Interim Study Results from OLE Study in ALS, page-6

  1. 3,301 Posts.
    lightbulb Created with Sketch. 1934
    Interesting update seems to be working still.

    - Some appear to be showing an increase in function. I wonder what the take is on this or is it just 'noise' in the somewhat subjective measurement.

    - P rating of pro-act vs traditional placebo group. While the P rating is statistically significant when comparing to pro-act, I wonder what fudge factor is built in to account for it not quite the same as placebo. I feel there is a gremlin hiding in this somewhere but perhaps it's just my sceptical curiosity. Does taking it to the most conservative numbers, somewhat account for this in the best way possible (because we will never know how placebo will actually work until the trial).




 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
17.0¢
Change
0.005(3.03%)
Mkt cap ! $83.69M
Open High Low Value Volume
16.5¢ 17.0¢ 16.5¢ $70.91K 420.5K

Buyers (Bids)

No. Vol. Price($)
4 104900 16.5¢
 

Sellers (Offers)

Price($) Vol. No.
17.0¢ 186536 2
View Market Depth
Last trade - 15.35pm 14/07/2025 (20 minute delay) ?
NUZ (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.